
FDA Leadership Upheaval Shakes U.S. Health Policy
Dr. Marty Makary stepped down as commissioner of the U.S. Food and Drug Administration after a contentious 13-month period. This period exposed deep divisions over public health policy, pharmaceutical regulation, and political influence inside one of America’s most powerful federal agencies. The resignation marks another major shakeup within the federal











